• Intramuscular Injection: 10 mg vial. ( 3) Contraindications • None with olanzapine monotherapy. ( 4) • When using olanzapine in combination with lithium or valproate, refer to the Contraindications section of the package inserts for those products. ( 4) Warnings and Precautions •...
Olanzapine injection is available as an olanzapine 10 mg vial. Who makes olanzapine? Various generic manufacturers make olanzapine, such as Apotex Inc., Dr Reddys Labs Ltd, and Zydus Pharms. Eli Lilly and Company makes the brand of olanzapine called Zyprexa. ...
fluoxetinein combination, also refer to the boxed warning section of the package insert for Symbyax. Common side effects Common side effects seen with olanzapine are: an inability to sit still (akathisia), constipation, dizziness, drowsiness, insomnia, dry mouth, orthostatic hypotension, tremor, an...
Dissolve the contents of the vial using 2.1 mL of Sterile Waterfor Injection to provide a solution containing approximately 5 mg/m2L of olanzapine. The resulting solution should appear clear and yellow. ZYPREXA IntraMuscular reconstituted with Sterile Water for Injection should be used immediately (wit...
Be aware that there are two ZYPREXA intramuscular formulations with different dosing schedules. ZYPREXA Intra Muscular (10 mg/vial) is a short-acting formulation and should not be confused with ZYPREXA RELPREVV. Refer to the package insert for ZYPREXA Intra Muscular for more information about that ...
What else should I know about olanzapine? What preparations of olanzapine are available? Tablets: 2.5, 5, 7.5, 10, 15, 20 mg. Tablets (orally disintegrating): 5, 10, 15, 20 mg. Injection (immediate release): 10 mg vial. Suspension for Injection (extended release): 210, 300, and 405...
Each vial provides for the administration of 10 mg (32 μmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3.5 mg tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been added during manufacturing to adjust pH. ...
Each vial provides for the administration of 10 mg (32 μmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3.5 mg tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been added during manufacturing to adjust pH. ...
Each vial provides for the administration of 10 mg (32 μmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3.5 mg tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been added during manufacturing to adjust pH. ...
Each vial provides for the administration of 10 mg (32 μmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3.5 mg tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been added during manufacturing to adjust pH. ...